Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates [3]

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 1, 2005, Pages 253-254

  Majoros, L ^a   Kardos, G ^a   Feiszt, P ^a   Szabo B ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Etest; Fungitest; Minimal fungicidal concentration

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA; ANTIFUNGAL AGENT;

ANTIBIOTIC SENSITIVITY; CANDIDA; CANDIDA INCONSPICUA; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; DRUG SCREENING; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; DRUG EFFECT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FLUCYTOSINE; HUMANS;

EID: 24044485301     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki174     Document Type: Letter

References (6)

1. Baily GG, Moore CB, Essayag SM [i#et al. Candida inconspicua#1i], a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. [i#Clin Infect Dis#1i] 1997; [b#25#1b]: 161-3.
2. Majoros L, Kardos G, Belák Á [i#et al.#1i] Restriction enzyme analysis of ribosomal DNA shows that [i#Candida inconspicua#1i] clinical isolates can be misidentified as [i#Candida norvegensis#1i] with traditional diagnostic procedures. [i#J Clin Microbiol#1i] 2003; [b#41#1b] 5250-3.
3. National Committee for Clinical Laboratory Standards. [i#Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A2#1i]. NCCLS, Wayne, PA, USA, 2002.
4. Nguyen MH, Clancy CJ, Yu VL [i#et al.#1i] Do the in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with [i#Candida#1i] fungemia. [i#J Infect Dis#1i] 1998; [b#177#1b]: 425-30.
5. Cantón E, Pemán J, Viudes A [i#et al.#1i] Minimum fungicidal concentrations of amphotericin B for bloodstream [i#Candida#1i] species. [i#Diagn Microbiol Infect Dis#1i] 2003; [b#45#1b]: 203-6.
6. Pfaller MA, Messer SA, Boyken L [i#et al.#1i] In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of [i#Candida#1i] spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. [i#Antimicrob Agents Chemother#1i] 2002; [b#46#1b]: 3518-21.